Histocytes and phagocytes were found in one patient. But detection of bacteria, virus and other pathogens were negative. In recent years, SFTSV (severe fever with thrombocytopenia syndrome virus)

infection was selleck kinase inhibitor reported in several provinces in China. It could cause multiple organ dysfunction. Change of WBC, PLT and serum enzymes were remarkably in these patients. The cases we reported here had the similar clinical features and laboratory findings with SFTS, and the clinical course of these cases consisted with virus infection. Unfortunately, neither SFTSV nor other pathogens have been detected in these cases so far. We supposed that SFTSV is not unique virus, it might be some other unknown virus or pathogens that could cause these

symptoms. More cases should be observed and further study should be done to confirm our hypothesis. Disclosures: The following people have nothing to disclose: Jie Cai, Xiling Guo, Yin Chen, Yiyue Ge, Lunbiao Cui, Yali Weng “
“The rapid emergence of nonalcoholic fatty liver disease (NAFLD) as a cause of both liver-related morbidity and mortality and cardiometabolic risk has led to the search for effective lifestyle strategies to reduce liver fat. Lifestyle intervention comprising dietary VX-770 mouse restriction in conjunction with increased physical activity has shown clear hepatic benefits when weight loss approximating 3%-10% of body weight is achieved. Yet, the poor sustainability of weight loss challenges the current therapeutic focus on body weight and highlights the need for alternative strategies for NAFLD management.

Epidemiologic data show an independent relationship between liver fat, physical activity, and fitness, Sodium butyrate and a growing body of longitudinal research demonstrates that increased physical activity participation per se significantly reduces hepatic steatosis and serum aminotransferases in individuals with NAFLD, independent of weight loss. Mechanistic insights to explain this interaction are outlined, and recommendations for the implementation of lifestyle intervention involving physical activity are discussed. In light of the often poor sustainability of weight loss strategies, and the viability of physical activity therapy, clinicians should assess physical fitness and physical activity habits, educate patients on the benefits of fitness outside of weight loss, and focus on behavior change which promotes physical activity adoption. (HEPATOLOGY 2010) Nonalcoholic fatty liver disease (NAFLD) affects ∼30% of adults and a majority of obese individuals.1 In addition to increasing morbidity and mortality from liver disease and cancer, excess liver fat is an independent risk factor for cardiovascular disease, insulin resistance, prediabetes and type 2 diabetes.1 Thus, strategies to modulate the burden of NAFLD are likely to have benefits beyond attenuating liver disease to the broader realm of obesity-related cardiometabolic risk reduction.